Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher E Barbieri

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2023
SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth SuppressionChuandong Geng, Man-Chao Zhang, Ganiraju C Manyam, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Cell-Autonomous AR Dependence in Luminal Prostatic Epithelium Governs Survival and Lineage PlasticityDan Li, Naitao Wang, Wangxin Guo, et al.
Journal of Translational Medicine|August 17, 2017
Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomicsHui Wang, Christopher E Barbieri, Jintang He, et al.
Nature Communications|April 26, 2020
Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypesDeli Liu, Jonathan E Shoag, Daniel Poliak, et al.
Nature Biotechnology|May 31, 2022
Identifying synergistic high-order 3D chromatin conformations from genome-scale nanopore concatemer sequencingAditya S Deshpande, Netha Ulahannan, Matthew Pendleton, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2023
Distinct mesenchymal cell states mediate prostate cancer progressionHubert Pakula, Mohamed Omar, Ryan Carelli, et al.
JCI Insight|January 20, 2022
Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer fociJacqueline Fontugne, Peter Y Cai, Hussein Alnajar, et al.
Neoplasia (New York, N.Y.)|February 25, 2014
SPOP mutations in prostate cancer across demographically diverse patient cohortsMirjam Blattner, Daniel J Lee, Catherine O'Reilly, et al.
JCO Precision Oncology|July 16, 2024
Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography: A Multicenter Retrospective StudyJohn Nikitas, Kritika Subramanian, Nimrod Barashi Gozal, et al.
European Urology Oncology|June 10, 2025
A Randomized Controlled Phase 2 Trial Comparing Salvage Radiotherapy for Prostate Cancer Delivered in 4 Versus 2 Weeks (SHORTER): Acute Genitourinary and Gastrointestinal Patient-reported Outcomes at a Single InstitutionHimanshu Nagar, Marshall A Diven, Brady Rippon, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2023
SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth SuppressionChuandong Geng, Man-Chao Zhang, Ganiraju C Manyam, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Cell-Autonomous AR Dependence in Luminal Prostatic Epithelium Governs Survival and Lineage PlasticityDan Li, Naitao Wang, Wangxin Guo, et al.
Journal of Translational Medicine|August 17, 2017
Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomicsHui Wang, Christopher E Barbieri, Jintang He, et al.
Nature Communications|April 26, 2020
Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypesDeli Liu, Jonathan E Shoag, Daniel Poliak, et al.
Nature Biotechnology|May 31, 2022
Identifying synergistic high-order 3D chromatin conformations from genome-scale nanopore concatemer sequencingAditya S Deshpande, Netha Ulahannan, Matthew Pendleton, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2023
Distinct mesenchymal cell states mediate prostate cancer progressionHubert Pakula, Mohamed Omar, Ryan Carelli, et al.
JCI Insight|January 20, 2022
Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer fociJacqueline Fontugne, Peter Y Cai, Hussein Alnajar, et al.
Neoplasia (New York, N.Y.)|February 25, 2014
SPOP mutations in prostate cancer across demographically diverse patient cohortsMirjam Blattner, Daniel J Lee, Catherine O'Reilly, et al.
JCO Precision Oncology|July 16, 2024
Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography: A Multicenter Retrospective StudyJohn Nikitas, Kritika Subramanian, Nimrod Barashi Gozal, et al.
European Urology Oncology|June 10, 2025
A Randomized Controlled Phase 2 Trial Comparing Salvage Radiotherapy for Prostate Cancer Delivered in 4 Versus 2 Weeks (SHORTER): Acute Genitourinary and Gastrointestinal Patient-reported Outcomes at a Single InstitutionHimanshu Nagar, Marshall A Diven, Brady Rippon, et al.
Pageof 11